摘要:
A disclosed data encoding apparatus includes: an arbitrary number of storage units; a data transfer control unit dividing input data into data blocks in accordance with the arbitrary number of storage units and transferring the data blocks to each storage unit; and encoding units having the same number as the storage units, the encoding units encoding the data blocks using a different cryptographic key for each storage unit while the data blocks are transferred by the data transfer control unit, wherein each storage unit stores the data blocks encoded by the encoding units.
摘要:
A cooling box to perform temperature control so that an internal temperature of the cooling box storing an item to be refrigerated becomes equal to a set temperature includes: a control device including an ambient-temperature sensor to detect an ambient temperature of the box, and adjust a supply amount of warm air into the box after stopping supply of cold air thereinto based on the ambient temperature; and a thermally-insulating-door sensor to detect whether an opening connected with the interior of the cooling box is in either an open or closed state, when the sensor detects a change of the opening from an open to closed state, the control device executing control so that the warm-air-supply-amount reaches a first value until a predetermined period has elapsed, and executing control so that the warm-air-supply-amount reaches a second value smaller than the first value after the predetermined period has elapsed.
摘要:
An apparatus and a method of controlling a light level of a light beam irradiated by a light source are provided. The light source is caused to irradiate the light beam having a light level determined based on a light level correction value for a specific main scanning position. The light level correction value is calculated based on light level change information indicating the change in the light level correction value for the specific main scanning position changes with respect to an initial light level correction value or a preceding light level correction value.
摘要:
Compounds, compositions and methods are provided that are useful in the treatment or prevention of a condition or disorder mediated by PPARγ. In particular, the compounds of the invention modulate the function of PPARγ. The subject methods are particularly useful in the treatment and/or prevention of diabetes, obesity, hypercholesterolemia, rheumatoid arthritis and atherosclerosis.
摘要:
A novel therapeutic agent for hyperlipidemia, which is an ester compound represented by the formula (1″) (wherein R1 and R2 are each hydrogen atom or optionally substituted aryl, etc.; X is —COO— or —CON(R10)—; R3 and R4 are each hydrogen atom, C1-C6alkyl or C1-C6alkoxy, etc.; R5, R6 and R7 are each hydrogen atom, C1-C6 alkyl or C1-C6 alkoxy, etc.; R8 and R9 are each independently hydrogen atom, C1-C6alkyl, —CON(R18)(R19) or —COO(R20), etc.; ring A, ring B and ring C are each independently aryl or heterocycle residue, etc.; Alk1 and Alk2 are each independently alkanediyl, etc.; l and m are each an integer of 0 or 1 to 3) or a prodrug thereof, or a pharmaceutically acceptable salt of either. The therapeutic agent selectively inhibits MTP in the small intestine, thus causes no such side effect as a fatty liver.
摘要:
A therapeutic agent for hyperlipidemia which has no side effects on the liver unlike conventional MTP inhibitors and has excellent MTP inhibitory activity. Also, provided is an ester compound represented by the general formula (1): or a pharmaceutically acceptable salt thereof.
摘要:
A novel therapeutic agent for hyperlipidemia, which is an ester compound represented by the formula (1″) (wherein R1 and R2 are each hydrogen atom or optionally substituted aryl, etc.; X is —COO— or —CON(R10)—; R3 and R4 are each hydrogen atom, C1-C6alkyl or C1-C6alkoxy, etc.; R5, R6 and R7 are each hydrogen atom, C1-C6 alkyl or C1-C6 alkoxy, etc.; R8 and R9 are each independently hydrogen atom, C1-C6alkyl, —CON(R18)(R19) or —COO(R20), etc.; ring A, ring B and ring C are each independently aryl or heterocycle residue, etc.; Alk1 and Alk2 are each independently alkanediyl, etc.; l and m are each an integer of 0 or 1 to 3) or a prodrug thereof, or a pharmaceutically acceptable salt of either. The therapeutic agent selectively inhibits MTP in the small intestine, thus causes no such side effect as a fatty liver.
摘要:
Compounds, compositions and methods are provided that are useful in the treatment or prevention of a condition or disorder mediated by PAPAR&ggr;. In particular, the compounds of the invention modulate the function of PAPAR&ggr;. The subject methods are particularly useful in the treatment and/or prevention of diabetes, obesity, hypercholesterolemia, rheumatoid arthritis and atherosclerosis.